Quest PharmaTech Financials
| QPTFF Stock | USD 0.01 0.00 0.00% |
Quest |
Quest PharmaTech Stock Summary
Quest PharmaTech competes with Coya Therapeutics,, Cue Biopharma, Lantern Pharma, Fennec Pharmaceuticals, and Eliem Therapeutics. Quest PharmaTech Inc., a pharmaceutical company, develops antibody based immunotherapeutic products for cancer. Further, the company develops products by using proprietary transdermal delivery technologies for dermatology and wound healing applications skin penetrating active molecules for cosmetic and pharmaceutical use and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest Pharmatech is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 8123 Roper Road |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.questpharmatech.com |
| Phone | 780 448 1400 |
| Currency | USD - US Dollar |
Quest PharmaTech Key Financial Ratios
There are many critical financial ratios that Quest PharmaTech's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Quest PharmaTech reports annually and quarterly.| Return On Equity | -0.62 | |||
| Return On Asset | -0.0038 | |||
| Number Of Employees | 11 | |||
| Beta | 0.84 | |||
| Z Score | 7.2 |
Quest Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Quest PharmaTech's current stock value. Our valuation model uses many indicators to compare Quest PharmaTech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Quest PharmaTech competition to find correlations between indicators driving Quest PharmaTech's intrinsic value. More Info.Quest PharmaTech is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Quest PharmaTech's earnings, one of the primary drivers of an investment's value.Quest PharmaTech Systematic Risk
Quest PharmaTech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Quest PharmaTech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was fourty-two with a total number of output elements of nineteen. The Beta measures systematic risk based on how returns on Quest PharmaTech correlated with the market. If Beta is less than 0 Quest PharmaTech generally moves in the opposite direction as compared to the market. If Quest PharmaTech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Quest PharmaTech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Quest PharmaTech is generally in the same direction as the market. If Beta > 1 Quest PharmaTech moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for Quest Pink Sheet analysis
When running Quest PharmaTech's price analysis, check to measure Quest PharmaTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest PharmaTech is operating at the current time. Most of Quest PharmaTech's value examination focuses on studying past and present price action to predict the probability of Quest PharmaTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest PharmaTech's price. Additionally, you may evaluate how the addition of Quest PharmaTech to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |